REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Korona-Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: KORONA-PHARMA Kereskedelmi es Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Korona-Pharma Bt. is an enterprise located in Hungary, with the main office in Nyiregyhaza. The enterprise operates in the Pharmacies and Drug Stores industry. It was incorporated on April 02, 1996. There are currently 19 (2024) people employed by Korona-Pharma Bt.. In 2023, the company reported a net sales revenue increase of 5.12%. Its’ total assets recorded a growth of 82.41%. Korona-Pharma Bt.’s net profit margin decreased by 5.75% in 2023.

Headquarters
Szabadsag ter 12/A.
Nyiregyhaza; Szabolcs-Szatmar-Bereg; Postal Code: 4400

Contact Details: Purchase the Korona-Pharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Korona-Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Korona-Pharma Bt. report to view the information.
Registered Capital:
Purchase the Korona-Pharma Bt. report to view the information.
Financial Auditors:
Purchase the Korona-Pharma Bt. report to view the information.
Incorporation Date:
April 02, 1996
Key Executives
Purchase this report to view the information.
Executive Officer
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
BREBEN INTERNATIONAL Kft.
Viridis-Pharma Kft.
Company Performance
Financial values in the chart are available after Korona-Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
5.12%▲
Total operating revenue
5.14%▲
Operating profit (EBIT)
-93.64%▼
EBITDA
-80.34%▼
Net Profit (Loss) for the Period
-84.61%▼
Total assets
82.41%▲
Total equity
-25.12%▼
Operating Profit Margin (ROS)
-6.51%▼
Net Profit Margin
-5.75%▼
Return on Equity (ROE)
-23.59%▼
Quick Ratio
-0.53%▼
Cash Ratio
-0.4%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo